CARERATINGNSECARE Ratings Limited· FinanceHighNeutral
Announced Wed, 13 May · 20:49 IST

CARE Ratings Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.

Pat Growth 25pctResults View source PDF

CARERATING · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+13.0%1-day move
₹1595.00
prior close
₹1700.10
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+3.9+2.2+0.8+1.3+13.0+8.4+10.7+8.0+7.6+6.6+0.6+3.4+3.9
Up moveDown movePending
AI summary

CARE Ratings Limited reported strong full-year results for FY 2026. Consolidated revenue from operations grew 17.6% to Rs. 47,307 lakhs from Rs. 40,232 lakhs in the prior year. Net profit after tax (attributable to owners) increased 24.7% to Rs. 17,118 lakhs versus Rs. 13,724 lakhs. EPS (basic) improved from Rs. 45.89 to Rs. 57.06. The Board recommended a final dividend of Rs. 14 per share (total FY 2026 dividend Rs. 22 per share including Rs. 8 interim). B S R & Co. LLP issued an unmodified audit opinion on both standalone and consolidated results. The company also announced re-appointment of B S R & Co. LLP as statutory auditors for 5 years and grant of 55,000 stock options to employees at Rs. 1,590 exercise price.

Likely market impact

CARE Ratings delivered healthy growth with PAT close to 25% and robust EPS improvement. The clean audit opinion and shareholder-friendly dividend policy are positive signals for investors.